Ultrasound-based machine learning models for predicting response to neoadjuvant chemotherapy in breast cancer: A meta-analysis
- 30 July 2025
- journal article
- research article
- Published by Elsevier in Clinical Imaging
- Vol. 125, 110574
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Deep Learning Model Based on Dual-Modal Ultrasound and Molecular Data for Predicting Response to Neoadjuvant Chemotherapy in Breast CancerAcademic Radiology, 2023
- Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancerEuropean Radiology, 2023
- Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter studyCancer, 2022
- Deep learning radiomics of ultrasonography can predict response to neoadjuvant chemotherapy in breast cancer at an early stage of treatment: a prospective studyEuropean Radiology, 2021
- Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional studyCancer Medicine, 2020
- Multiparametric MRI-based radiomics analysis for prediction of breast cancers insensitive to neoadjuvant chemotherapyClinical and Translational Oncology, 2019
- MRI and PET/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysisThe Breast, 2018
- Radiomics Analysis on Ultrasound for Prediction of Biologic Behavior in Breast Invasive Ductal CarcinomaClinical Breast Cancer, 2018
- Taxanes as primary chemotherapy for early breast cancerCancer, 2008
- Neoadjuvant chemotherapy for operable breast cancerBritish Journal of Surgery, 2007